Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SA01d
- Development stage
- Phase 3
- Lead developer
- Syqe Medical
- Modality
- Small Molecules
- Administration
- Inhalation
01
Overview
SA01d is a clinical-stage pharmaceutical program developed by Kensana Health that utilizes the SyqeAir metered-dose inhaler to deliver standardized medical cannabis. The program is specifically designed to evaluate the safety and functional impact of inhaled cannabinoids on cognitive function and driving performance. By employing the SyqeAir device, which allows for the precise aerosolization of granular cannabis flos, SA01d aims to achieve predictable pharmacokinetic profiles and minimize the psychoactive impairment often associated with non-standardized cannabis use. This precision-dosing approach is intended to support the safe use of medical cannabis in patients who need to maintain high levels of functional capability in their daily lives. SA01d is currently in Phase 4 development, focusing on real-world safety outcomes and functional assessments.
- Other names
- SyqeAir
02
Targets
CNR1 (Cannabinoid receptor 1)FAAHGPR55 (G protein-coupled receptor 55)PPARG (Peroxisome proliferator-activated receptor gamma)TRPV1 (Transient receptor potential cation channel subfamily V member 1)
Beyond the preview
Go deeper on SA01d.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SA01d.